CLINICAL PHARMACOLOGY CONSULTATION AND OUTCOMES ASSOCIATED WITH PREGNANCY EXPOSURE TO FDA CATEGORY X DRUGS

被引：0
|
作者：
Turk, Erdeljic, V
Francetic, I
Ksenija, M.
Matea, R.
Robert, L.
机构：
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2014年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
200
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [31] Patient Relevant Outcomes Associated with Generic Drugs in FDA's Adverse Event Reporting System
    Marimuthu, Sathiya Priya
    Iyer, Geetha S.
    Segal, Jodi B.
    Singh, Sonal
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 421 - 422
  • [32] EXPOSURE OF DRUGS FOR AUTOIMMUNE DISEASE DURING PREGNANCY AND PERINATAL OUTCOMES: AN INVESTIGATION OF THE REGULATOR IN JAPAN
    Sato, R.
    Ikuma, M.
    Takagi, K.
    Asano, J.
    Yamagishi, Y.
    Matsunaga, Y.
    Watanabe, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1164 - 1164
  • [33] In utero exposure to antiretroviral drugs and pregnancy outcomes: Analysis of the French ANRS pharmacovigilance database
    Saint-Lary, Laura
    Diallo, Alpha
    de Monteynard, Laure-Amelie
    Paul, Christelle
    Marchand, Lucie
    Tubiana, Roland
    Warszawski, Josiane
    Mandelbrot, Laurent
    Rekacewicz, Claire
    Petrov-Sanchez, Ventzislava
    Faye, Albert
    Sibiude, Jeanne
    Dabis, Francois
    Sommet, Agnes
    Leroy, Valeriane
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (03) : 942 - 964
  • [34] Clinical pharmacology information in regulatory submissions and labeling: A comparative analysis of orphan and non-orphan drugs approved by the FDA
    Hsieh, Julie
    Sahre, Martina
    Yang, Xinning
    Madabushi, Rajanikanth
    Ramamoorthy, Anuradha
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (11): : 2583 - 2596
  • [35] Ethical, Economic, Societal, Clinical, and Pharmacology Uncertainties Associated With Milasen and Other Personalized Drugs
    Amariles, Pedro
    Madrigal-Cadavid, Juliana
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (09) : 937 - 938
  • [36] Clinical, Sociodemographic, and Neighborhood Characteristics Associated with Adverse Pregnancy Outcomes
    Thermidor, Sadiya
    Gaballa, Dianna
    Hentz, Roland
    Fishbein, Joanna
    Vaidean, Georgeta
    Weinberg, Catherine
    Pachtman, Sarah
    Blitz, Matthew J.
    Grayver, Evelina
    Gianos, Eugenia
    JOURNAL OF WOMENS HEALTH, 2024, 33 (03) : 308 - 317
  • [37] Clinical features and risk factors associated with prenatal exposure to drugs of abuse
    Roca, Antonia
    Jarque, Pilar
    Gomila, Isabel
    Marchei, Emilia
    Tittarelli, Roberta
    Angel Elorza, Miguel
    Sanchis, Pilar
    Barcelo, Bernardino
    ANALES DE PEDIATRIA, 2021, 95 (05): : 307 - 320
  • [38] Birth and early developmental screening outcomes associated with cannabis exposure during pregnancy
    Elyse Olshen Kharbanda
    Gabriela Vazquez-Benitez
    Alicia Kunin-Batson
    James D. Nordin
    Avalow Olsen
    Paul A. Romitti
    Journal of Perinatology, 2020, 40 : 473 - 480
  • [39] Prenatal exposure to antidepressants is associated with small but significant differences in pregnancy and delivery outcomes
    Galbally, Megan
    Lewis, Andrew James
    EVIDENCE-BASED MENTAL HEALTH, 2013, 16 (03) : 89 - 89
  • [40] Birth and early developmental screening outcomes associated with cannabis exposure during pregnancy
    Kharbanda, Elyse Olshen
    Vazquez-Benitez, Gabriela
    Kunin-Batson, Alicia
    Nordin, James D.
    Olsen, Avalow
    Romitti, Paul A.
    JOURNAL OF PERINATOLOGY, 2020, 40 (03) : 473 - 480
12345